PBS Biotech® Launches Single-Use Bioreactor for Development of New Vaccines and Biosimilars
Benchtop size, plug and play bioreactor in tandem with the low profile
and high performance ATF™ System on display at ESACT in Vienna
PBS bioreactors feature low shear mixing and high mass transfer rates from the patented Air Wheel™ mixing mechanism, making them a perfect complement to the Refine Technology ATF™ System which provides a reliable and efficient process of cell separation and supports cell growth to extreme concentrations. The ATF System allows increased volumetric productivity and reduced bioreactor size. Together the PBS Biotech single-use bioreactors and the Refine Technology perfusion systems are ideal for demanding R&D laboratory to clinical stage high-density cell culture applications including:
About PBS Biotech
PBS Biotech, Inc. is a U.S. corporation headquartered in Camarillo, California that manufactures fully scalable and easy-to-use single-use bioreactors for global biotechnology organizations. The company has developed innovative, efficient, and scalable bioreactors by combining a patented pneumatic mixing mechanism with an advanced, proprietary control system. This novel bioreactor solution offers improved operational efficiency and flexibility with reduced costs and ultimately shorter time to market for biotechnology customers. PBS Biotech is poised for rapid growth by supporting industry demand for single-use technologies.
About Refine Technology
Refine Technology was founded in 1999 with a vision to bring to the biopharmaceutical market cell separation systems that allow for increased productivity of cell derived biopharmaceuticals. Refine soon introduced its patented ATF System which is now being used in the development and manufacturing facilities of many biological and pharmaceutical companies.
PBS Biotech® Contact: Rick Sullivan, VP Sales & Marketing
Refine Technology Contact: John Bonham-Carter, VP – Sales & Business Development
+1 (732) 993-3003 and EU +46 76 256 5114